TPP leak: Sweeping IP protections will block biosimilars, MSF says
A leaked draft of Trans-Pacific Partnership negotiations reveals US plans to massively broaden IP for biologics and opens the door to monopolies, says MSF.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs